Co-Diagnostics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
Co-Diagnostics, Inc. (CODX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of 1.80% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2025-03-27
- Co-Diagnostics, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2024 was 1.80%, a 60.87% decline from fiscal 2023.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2023 was 4.60%.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2022 was -11.10%, a 526.92% decline from fiscal 2021.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2021 was 2.60%, a 30.00% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 1.80% 10-K · filed 2025-03-27 | |
| 2023-12-31 | 4.60% 10-K · filed 2025-03-27 | -4.60% 10-K · filed 2024-03-14 |
| 2022-12-31 | -11.10% 10-K · filed 2024-03-14 | |
| 2021-12-31 | 2.60% 10-K · filed 2023-03-16 | |
| 2020-12-31 | 2.00% 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |